MedTrace Logo

Community Dining, Walking, and Glucose in Older Adults

NCT07695675 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-07-20

No results posted yet for this study

Summary

This study will examine whether eating lunch and dinner at a subsidized community dining site affects postmeal walking and blood glucose patterns in older adults. Participants will be community-dwelling adults aged 60 to 79 years who are eligible for a local elderly meal subsidy and have prediabetes or elevated blood glucose risk.

Each participant will complete two 6-day meal conditions in random order. In one condition, participants will eat lunch and dinner at home. In the other condition, participants will eat lunch and dinner at a subsidized community dining site. Participants will wear a continuous glucose monitor and an activity tracker so the study team can measure postmeal glucose levels, daily glucose patterns, and steps after meals.

The study will compare community dining with home eating to determine whether community dining increases postmeal walking, improves postmeal glucose responses, and affects loneliness and meal experience.

Conditions

Interventions

BEHAVIORAL

Subsidized Community Dining

Participants will eat lunch and dinner at a subsidized community dining site for 6 days. No walking target or exercise prescription will be given. After each meal, participants will be free to walk, sit, rest, remain at the dining site, or return home according to their usual preference.

BEHAVIORAL

Home Eating

Participants will eat lunch and dinner at home for 6 days using a standardized Chinese meal rotation designed to approximate the energy and macronutrient composition of the community dining meals.

Sponsors & Collaborators

  • Yang Zhang

    lead OTHER

Principal Investigators

  • Yang Zhang, PhD

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07695675 on ClinicalTrials.gov